Stock: Page 2
LumiraDx Q2 revenues down 49% on drop in COVID testing
August 17, 2022
Agilent Technologies Q3 revenues rise 8%
August 16, 2022
Sophia Genetics revenues up 15% on platform volumes
August 8, 2022
VolitionRx prices $6M public offering
July 28, 2022
LumiraDx prices $75.3M public offering
July 20, 2022
Danaher Q2 diagnostics revenues rise 9%
July 20, 2022
Most Popular
LumiraDx announces proposed share offering
July 18, 2022
Centogene Q1 year-over-year revenues rise 3%
July 14, 2022
Sophia names Ken Freedman as chief revenue officer
January 26, 2022
Lucid closes Nasdaq initial public offering
October 19, 2021
Lucid Diagnostics files for IPO on Nasdaq exchange
September 22, 2021